Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Home > Insider Trading > Kenneth Bate > Profile

Kenneth Bate

Affiliations

Director at Aveo Pharmaceuticals Inc. (AVEO), 2020-06-30
Director at Genocea Biosciences Inc. (GNCA), 2020-06-19
Director at Madrigal Pharmaceuticals Inc. (MDGL), 2020-06-18
Director at Catabasis Pharmaceuticals Inc (CATB), 2020-06-12
Director at Epizyme Inc. (EPZM), 2020-06-02
Director at Vanda Pharmaceuticals Inc. (VNDA), 2017-06-20
Director at Biomarin Pharmaceutical Inc (BMRN), 2015-06-18
Director at Cubist Pharmaceuticals Inc (CBST), 2015-01-21

Insider Trading: Sales See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Cubist Pharmaceuticals Inc	CBST	$72.83	1,000	Director	7,914	2014-02-03	Filing
Cubist Pharmaceuticals Inc	CBST	$72.02	5,250	Director	8,914	2014-02-03	Filing
Cubist Pharmaceuticals Inc	CBST	$70.00	10,000	Director	7,914	2014-01-09	Filing
Cubist Pharmaceuticals Inc	CBST	$68.10	2,206	Director	7,914	2013-12-02	Filing
Cubist Pharmaceuticals Inc	CBST	$67.53	10,294	Director	10,120	2013-12-02	Filing